Physician profile
Achankeng Afiadata
NPI 1851786321
$6,767.99
in general payments reported to CMS, 2019-2025
29 companies · $1,152 in 2025
The $1,152 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,464 · 2020: $140 · 2021: $976 · 2022: $879 · 2023: $1,826 · 2024: $330 · 2025: $1,152.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,486 · Travel and Lodging: $822.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,486.06 |
| Travel and Lodging | $822.35 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $1,806.33 | 2019-2025 | Moses, Moses 550 Dfl, General - Male Sui |
| Intuitive Surgical, INC. | $1,364.45 | 2023 | Da Vinci Surgical System |
| Dendreon Pharmaceuticals LLC | $894.93 | 2019-2025 | Provenge |
| Astellas Pharma US INC | $662.46 | 2021-2023 | Xtandi |
| Tolmar, INC. | $247.21 | 2025 | Eligard |
| Procept Biorobotics Corporation | $232.35 | 2025 | |
| Sumitomo Pharma America, INC. | $176.07 | 2023-2025 | Gemtesa |
| Janssen Biotech, INC. | $145.75 | 2022-2025 | Erleada |
| Abbvie INC. | $143.97 | 2020-2022 | |
| Coloplast Corp | $122.28 | 2021-2025 | Speedicath, Altis |
| Teleflex LLC | $120.17 | 2021-2025 | Barrigel, Urolift |
| Bayer Healthcare Pharmaceuticals INC. | $119.61 | 2021-2023 | |
| Myovant Sciences INC. | $85.57 | 2021 | |
| Urovant Sciences INC | $83.29 | 2021-2022 | |
| Baxter Healthcare | $75.52 | 2021-2025 | Tisseel |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Blue Earth Diagnostics | $67.91 | 2022 | |
| Philips North America LLC | $59.26 | 2023 | |
| Genzyme Corporation | $50.92 | 2022 | |
| Ethicon US, LLC | $44.06 | 2021-2022 | |
| Allergan, INC. | $40.19 | 2021 | |
| Travere Therapeutics, INC. | $39.79 | 2019-2021 | |
| Pfizer INC. | $35.92 | 2021-2022 | |
| Medtronic, INC. | $34.52 | 2022 | |
| Urogen Pharma, INC. | $23.42 | 2025 | |
| Olympus America INC. | $21.04 | 2022 | |
| Antares Pharma, INC. | $21.03 | 2021 | |
| Ferring Pharmaceuticals INC. | $19.53 | 2025 | Adstiladrin |
| Axonics, INC. | $17.82 | 2021 | |
| Photocure INC | $12.62 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Achankeng Afiadata listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.